Company Sanofi

SAN

FR0000120578

Pharmaceuticals

Market Closed - Euronext Paris Other stock markets 10:25:00 13/03/2026 pm IST			5-day change	1st Jan Change
76.39 ^EUR	-0.17%		0.00%	-7.65%

11/03	Brazil drugmaker EMS eyes overseas deals after buying Sanofi unit	RE
09/03	Global drugmakers rush to boost US presence as tariff threat looms	RE

Business description: Sanofi

Sanofi is the largest European pharmaceutical group. Net sales by family of products break down as follows:

- pharmaceutical products (81.8%): prescription drugs for the treatment of multiple sclerosis, neurological diseases, inflammatory diseases, autoimmune diseases, rare diseases, cancers and rare hematological diseases;

- human vaccines (18.2%): pediatric vaccines, vaccines for flu, meningitis, and polio, booster vaccines, and vaccines for travelers and endemic areas.

At the end of 2025, the group had 37 production sites worldwide.

Net sales are distributed geographically as follows: France (3.9%), Europe (17.1%), the United States (50.8%), China (6%) and other (22.2%).

Number of employees: 74,846

Sales by Activity: Sanofi

Fiscal Period: December	2021 (EUR)	2022 (EUR)	2023 (EUR)	2024 (EUR)	2025 (EUR)
Biopharma	-	-	4.12TCr	4.39TCr	4.62TCr
Consumer Healthcare	452.3Cr	514.2Cr	523.2Cr	-	-
Pharmaceuticals Excl. Consumer Healthcare	2.72TCr	3.13TCr	-	-	-
Vaccines	741.8Cr	889.5Cr	-	-	-
Others	-	70L	-	34Cr	49Cr

See all business segments

Geographical breakdown of sales: Sanofi

Fiscal Period: December	2021 (EUR)	2022 (EUR)	2023 (EUR)	2024 (EUR)	2025 (EUR)
United States	1.44TCr	1.83TCr	1.85TCr	2TCr	2.22TCr
Rest of The World	785Cr	838.6Cr	1.35TCr	1.21TCr	966Cr
Europe (Excluding France)	-	-	801.3Cr	721.3Cr	745.9Cr
China	272Cr	312.3Cr	-	-	262.1Cr
France	-	-	237.9Cr	181.4Cr	171Cr
Europe (Excl. Russia)	975.9Cr	999.9Cr	-	-	-
Russia	58Cr	67Cr	-	-	-
Brazil	82Cr	93Cr	-	-	-
North America (Excluding United States)	-	-	70Cr	-	-
Japan	165.7Cr	161.3Cr	-	-	-

See all geographic segments

Executive Committee: Sanofi

Manager	Title	Age	Since
Olivier Antoine M. Charmeil CEO	Chief Executive Officer	61	17/02/2026
François-Xavier Roger DFI	Director of Finance/CFO	63	01/04/2024
Madeleine Roach COO	Chief Operating Officer	41	01/10/2023
Houman Ashrafian CTO	Chief Tech/Sci/R&D Officer	51	11/09/2023
Thomas Kudsk Larsen IRC	Investor Relations Contact	52	15/03/2024

See SANOFI governance

Composition of the Board of Directors: Sanofi

Director	Title	Age	Since
Patrick Kron BRD	Director/Board Member	72	01/05/2014
Christophe Babule BRD	Director/Board Member	60	30/04/2019
Rachel Duan BRD	Director/Board Member	55	28/04/2020
Lise Kingo BRD	Director/Board Member	64	28/04/2020
Barbara Lavernos BRD	Director/Board Member	57	30/04/2021
Wolfgang Laux BRD	Director/Board Member	58	01/04/2021
Carole Ferrand BRD	Director/Board Member	54	03/05/2022
Emile Voest BRD	Director/Board Member	66	03/05/2022
Antoine Yver BRD	Director/Board Member	68	03/05/2022
Frédéric Oudéa CHM	Chairman	62	25/05/2023

Composition of the Board of Directors

Shareholders: Sanofi

Name	Equities	%	Valuation
L'ORÉAL 7.271 %	8,86,70,657	7.271 %	8 606 M €
SANOFI 0.981 %	1,19,62,777	0.981 %	1 161 M €
OFI Invest Asset Management SA 0.2939 %	35,84,019	0.2939 %	348 M €
Goldman Sachs Asset Management BV 0.164 %	20,00,338	0.164 %	194 M €
State Street Global Advisors Ltd. 0.1395 %	17,01,794	0.1395 %	165 M €

Name	Equities	%	Valuation
Dodge & Cox 2.316 %	5,64,92,599	2.316 %	2 749 M €
Fisher Asset Management LLC 0.4978 %	1,21,40,615	0.4978 %	591 M €
Eaton Vance Management 0.3732 %	91,02,196	0.3732 %	443 M €
Merrill Lynch International 0.3503 %	85,44,008	0.3503 %	416 M €
Barrow, Hanley, Mewhinney & Strauss LLC 0.2857 %	69,68,413	0.2857 %	339 M €

List of SANOFI shareholders

Holdings: Sanofi

Name	Equities	%	Valuation
SANOFI 0.98%	1,19,62,777	0.98%	1 161 M $
SANOFI 60.4%	1,39,09,587	60.4%	686 M $
SANOFI INDIA LIMITED 60.4%	1,39,09,587	60.4%	606 M $
MEIRAGTX HOLDINGS PLC 15.15%	1,21,97,737	15.15%	92 M $
MEIRAGTX HOLDINGS PLC 7.96%	11,57,926	7.96%	86 M $
EUROAPI 29.6%	2,82,98,074	29.6%	72 M $
NOVAVAX, INC. 4.23%	68,80,481	4.23%	70 M $
ANAPTYSBIO, INC. 2.97%	8,21,917	2.97%	45 M $
VICORE PHARMA HOLDING AB 5.18%	1,45,71,428	5.18%	16 M $
MAPLIGHT THERAPEUTICS, INC. 2.01%	9,12,041	2.01%	16 M $

Company details: Sanofi

Sanofi

46, avenue de la Grande Armée

75017, Paris

+33 1 53 77 40 00

http://www.sanofi.com

Group companies: Sanofi

Name	Category and Sector
SANOFI INDIA LIMITED	Pharmaceuticals: Major
SANOFI INDIA LIMITED	Pharmaceuticals: Major
Sanofi Healthcare India Pvt Ltd. Sanofi Healthcare India Pvt Ltd. BiotechnologyHealth Technology Develops and manufactures vaccines	Biotechnology
Sanofi Aventis Paraguay SA
Sanofi Manufacturing Pte Ltd.

See all subsidiaries

Other Pharmaceuticals

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi.($)
SANOFI	-0.17%	0.00%	-28.08%	-13.22%	11TCr
ELI LILLY AND COMPANY	+0.80%	-0.53%	+22.88%	+203.58%	88TCr
JOHNSON & JOHNSON	-0.21%	+0.47%	+48.18%	+57.79%	58TCr
ABBVIE INC.	-2.52%	-4.53%	+3.84%	+44.57%	39TCr
ROCHE HOLDING AG	+0.79%	-6.01%	+5.81%	+21.36%	32TCr
ASTRAZENECA PLC	+0.11%	-0.83%	+21.02%	+34.57%	30TCr
NOVARTIS AG	+0.43%	-1.54%	+25.20%	+62.42%	29TCr
MERCK & CO., INC.	-0.26%	-0.16%	+22.07%	+9.34%	29TCr
AMGEN INC.	-0.43%	-0.90%	+17.13%	+57.05%	20TCr
GILEAD SCIENCES, INC.	+0.42%	+0.74%	+27.91%	+82.35%	18TCr
Average	-0.28%	-1.33%	+16.60%	+55.98%	35.32TCr
Weighted average by Cap.	-0.38%	-1.33%	+21.77%	+82.93%